Lanean...
Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination
The U.S. Food and Drug Administration (FDA) recently issued an Emergency Use Authorization (EUA) for two highly effective Sars-CoV-2 (COVID-19) vaccines from Pfizer-BioNTech and Moderna. More recently, EUA was granted for the Johnson and Johnson COVID-19 vaccine which uses traditional virus-based te...
Gorde:
| Argitaratua izan da: | Am J Emerg Med |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier Inc.
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8095021/ https://ncbi.nlm.nih.gov/pubmed/33980419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajem.2021.05.001 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|